Document Type
Article
Publication Date
2009
ISSN
0278-2715
Publisher
Project HOPE
Language
En-US
Abstract
Congress may reform drug pricing policies under Medicare Part D as part of a larger health reform effort. Currently, the "noninterference" provision prevents the government from negotiating drug prices on behalf of Medicare Part D prescription drug plans. Commonly considered reform proposals borrow ideas from Medicaid, either through returning dual eligibles to Medicaid drug pricing or by imposing mandatory rebates across the Part D population. We examine a menu of other options, including value-based pricing; expansion of generic and therapeutically equivalent substitution; increased formulary diversity; importation; and limited antitrust waivers. These latter options may reduce federal spending without direct government price negotiations.
Recommended Citation
Kevin Outterson,
How Medicare Could Get Better Prices on Prescription Drugs
,
in
28
Health Affairs
832
(2009).
Available at:
https://scholarship.law.bu.edu/faculty_scholarship/493
